Valuation Integra LifeSciences Holdings Corporation
Stocks
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
02:30:00 13/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 14.35 USD | -2.84% |
|
+1.63% | +15.54% |
Company Valuation: Integra LifeSciences Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 5,674 | 4,683 | 3,405 | 1,750 | 967.4 | 1,116 | - | - |
| Change | - | -17.47% | -27.3% | -48.6% | -44.72% | 15.4% | - | - |
| Enterprise Value (EV) 1 | 6,707 | 5,670 | 4,605 | 3,285 | 2,563 | 2,924 | 2,422 | 2,243 |
| Change | - | -15.47% | -18.78% | -28.66% | -21.98% | 14.07% | -17.15% | -7.4% |
| P/E | 33.8x | 26x | 51.8x | -252x | -1.84x | 29.3x | 13x | 10.9x |
| PBR | 3.37x | 2.6x | 2.14x | 1.13x | 0.93x | 1.31x | 0.87x | 0.79x |
| PEG | - | 2.86x | -0.8x | 2x | -0x | -0x | 0x | 0.6x |
| Capitalization / Revenue | 3.68x | 3.01x | 2.21x | 1.09x | 0.59x | 0.68x | 0.67x | 0.64x |
| EV / Revenue | 4.35x | 3.64x | 2.99x | 2.04x | 1.57x | 1.78x | 1.45x | 1.29x |
| EV / EBITDA | 16.7x | 13.8x | 12.5x | 10.2x | 8.07x | 9.1x | 7.04x | 6.08x |
| EV / EBIT | 21.4x | 15.5x | 14x | 11.7x | 9.33x | 10.5x | 8.01x | 6.81x |
| EV / FCF | 25.4x | 25.5x | 63x | 132x | -82.5x | 23.2x | 13.5x | 15.2x |
| FCF Yield | 3.94% | 3.92% | 1.59% | 0.76% | -1.21% | 4.31% | 7.41% | 6.58% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.98 | 2.16 | 0.84 | -0.09 | -6.74 | 0.49 | 1.102 | 1.32 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,542 | 1,558 | 1,542 | 1,611 | 1,635 | 1,644 | 1,675 | 1,737 |
| EBITDA 1 | 400.7 | 411.3 | 369.7 | 322.2 | 317.5 | 321.2 | 344 | 368.9 |
| EBIT 1 | 314.1 | 366.6 | 329.1 | 281.1 | 274.8 | 277.6 | 302.4 | 329.2 |
| Net income 1 | 169.1 | 180.6 | 67.74 | -6.944 | -516.5 | 35.57 | 69.57 | 88.23 |
| Net Debt 1 | 1,033 | 986.7 | 1,200 | 1,535 | 1,596 | 1,807 | 1,306 | 1,127 |
| Reference price 2 | 66.99 | 56.07 | 43.55 | 22.68 | 12.42 | 14.35 | 14.35 | 14.35 |
| Nbr of stocks (in thousands) | 84,700 | 83,518 | 78,176 | 77,164 | 77,892 | 77,801 | - | - |
| Announcement Date | 23/02/22 | 22/02/23 | 28/02/24 | 25/02/25 | 26/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 29.29x | 1.78x | 9.1x | -.--% | 111.64Cr | ||
| 35.48x | 4.19x | 15.73x | 2.42% | 19TCr | ||
| 21.86x | 3.71x | 13.29x | 2.81% | 12TCr | ||
| 26.94x | 4.79x | 16.44x | 1.15% | 12TCr | ||
| 31.57x | 3.04x | 12.28x | 2.26% | 9.14TCr | ||
| 18.53x | 0.22x | 13.79x | 0.68% | 6.67TCr | ||
| 43.97x | 3.87x | 13.18x | 1.94% | 5.88TCr | ||
| 46.33x | 11.64x | 32.65x | -.--% | 5.5TCr | ||
| 28.86x | 7.15x | 18.14x | 1.39% | 4.99TCr | ||
| 52.13x | 1.44x | 13.34x | -.--% | 3.51TCr | ||
| Average | 33.50x | 4.18x | 15.79x | 1.26% | 8TCr | |
| Weighted average by Cap. | 31.86x | 4.30x | 15.92x | 1.74% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IART Stock
- Valuation Integra LifeSciences Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
















